PATENT CLAIM ANALYSIS

Application Number: 15764188
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["514", "019300"]

Abstract:
The disclosure provides compositions comprising peptide-based nanofiber precursors and methods of using the same to inhibit cancerous cell growth and/or to deliver therapeutic or diagnostic agents to cells, e.g., cancerous cells. The compositions of the present technology include peptide-based nanofiber precursors as well as carrier complexes comprising a therapeutic or diagnostic agent, and a peptide-based nanofiber precursor. Also provided herein are methods for delivering a therapeutic or diagnostic agent to a cell comprising contacting the cell with a carrier complex including a therapeutic or diagnostic agent, and a peptide-based nanofiber precursor.

Claim (Index 34):
The method of  claim 28 , wherein the peptide-based nanofiber is administered orally, topically, intranasally, systemically, locally intramuscularly, intravenously, subcutaneously, intracerebroventricularly, intrathecally, intratumorally, transdermally or with iontophoresis.

Metadata:
- Claim Count in Document: 10.0
- Percentile: 90.0
- Lexical Diversity: 2.0
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14209757', '13642081', '14005442', '11967509', '14211557']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7334493151890545
- 35 USC 102 Novelty (BERT): 0.5206518051425542
- Combined Prediction Score: 0.7121695641844046
- Mean Citation Score: 243.741852
- Max Citation Score: 273.43457
- Similarity Product: 181.3305180152351

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test